HERA CD FORTY

Brand	Owner	Address	Description
HERA-CD40	Apogenix AG	Im Neuenheimer Feld 584 69120 Heidelberg Germany	HERA-CD FORTY; HERA-CD FOUR ZERO;Scientific services, namely, scientific and pharmaceutical research in the field of oncology and immunology relating to fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety; scientific and technological services, namely, protein design and protein engineering in the field of oncology and immunology relating to fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety; scientific consulting services in the field of protein design and protein engineering regarding fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety and providing scientific information in the field of protein design and protein engineering regarding fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

A system and method is disclosed for selectively increasing a wet etch rate of a large raised area portion of a semiconductor wafer with respect to a wet etch rate of a small raised area portion of the semiconductor wafer. A resist mask on the semiconductor wafer is etched to create a large via over the large raised area portion and a small via over the small raised area portion. An ion implantation beam is applied with an impact direction that enables ions to pass through the large via but does not enable ions to pass through the small via. The ions that pass through the large via increase the wet etch rate of the underlying portion of the semiconductor wafer. In one embodiment the impact direction has a tilt angle of forty five degrees and a rotation angle of forty five degrees.